levofloxacin has been researched along with Airflow Obstruction, Chronic in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (44.12) | 29.6817 |
| 2010's | 18 (52.94) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Adel, S; Ahmed, A; Asma, B; Hamdi, B; Imen, T; Kaouthar, B; Khaoula, BHA; Mehdi, M; Mohamed Amine, M; Mohamed Habib, G; Mohamed Hassene, K; Nadia, BB; Rabie, R; Riadh, B; Selma, M; Semir, N; Wahid, B; Yosra, BD | 1 |
| Aslan, S; Aykent, A; Ignak, S; Karadağ, G; Soydan, S; Unay Demirel, O | 1 |
| Hibi, A; Kumano, Y | 1 |
| Bacchin, R; Cardellini, D; Gajofatto, A; Macchione, F; Orlandi, R; Vattemi, G; Zanusso, G | 1 |
| Blasi, F; Centanni, S; Del Vecchio, A; Dionisio, P; Rosignoli, MT; Schaberg, T | 1 |
| Calzetta, L; Cazzola, M; Fiori, E; Rogliani, P; Sabatini, M; Segreti, A; Segreti, V | 1 |
| Astaf'ev, AV; Sinopal'nikov, AI; Styrt, EA | 1 |
| Chung, HS; Han, SK; Kim, DK; Kim, JY; Kim, YW; Lee, CH; Lee, CT; Lee, JH; Lee, SM; Park, GM; Yim, JJ; Yoo, CG; Yoon, HI | 1 |
| Drake, WP; Isom, JM; Oswald-Richter, K; Richmond, BW; Shipley, GR; Worrell, JA; Yu, C | 1 |
| Jones, P; Leidy, NK; Murray, LT; Sethi, S | 1 |
| Bafadhel, M; Brightling, CE; Monteiro, W; Pavord, ID; Siva, R | 1 |
| Furqan, S; Paracha, SA | 1 |
| Ardanuy, C; Calatayud, L; de la Campa, AG; Garmendia, J; Liñares, J; Marti, S; Puig, C; Tirado-Vélez, JM; Tubau, F | 1 |
| Araujo, MC; dos Santos, UM; Fachinelli, LR; Martins, RR; Modesto dos Santos, V; Ribeiro, KD | 1 |
| Blasi, F; Bonizzoni, E; Campanini, M; Casali, A; Colagrande, P; Giusti, M; Gussoni, G; Iori, I; Mazzone, A; Politi, C; Sgambato, F; Valerio, A | 1 |
| Gent, JF; Holden, PN; Kong, Y; Murphy, TF; Pettigrew, MM; Sethi, S; Tsuji, BT | 1 |
| Blasi, F | 1 |
| Guchev, IA; Iudenich, OV; Melekhina, EV | 1 |
| Baughman, RP; Nicolau, DP; Sutherland, C; Winget, D | 1 |
| Aaron, SD; Bourbeau, J; Field, SK; FitzGerald, JM; Mallick, R; Maltais, F; Marciniuk, DD; Nair, P; Sin, DD; Vandemheen, KL | 1 |
| Casal, J; Martínez Benazet, J; Roig, J | 1 |
| Malcolm, C; Marrie, TJ | 1 |
| Apelqvist, J; Eneroth, M; Larsson, J; Melhus, A | 1 |
| Eller, J; Ioanas, M; Linnhoff, A; Lode, H | 1 |
| Ercibengoa, M; González, A; Larruskain, J; Marimón, JM; Pérez-Trallero, E | 1 |
| Castiella Herrero, J; Naya Machado, J; Sánchez Muñoz, LA; Sanjuán Portugal, FJ | 1 |
| Falguera, M; Giménez, A; Gómez-Arbonés, X; Porcel, JM; Ruiz-González, A; Sánchez, V; Soler-González, J | 1 |
| Choné, C; Petitpretz, P; Trémolières, F | 1 |
| Conte, JE; Golden, JA; Little, E; McIver, M; Zurlinden, E | 1 |
| Meda, KP; Parmar, C | 1 |
| Maurin, N | 1 |
| Guinea, O; Noval Menéndez, J; Nuño Mateo, FJ; Suárez, M | 1 |
| Ahmed, S; Karim, A; Rossoff, LJ; Siddiqui, RK; Steinberg, HN | 1 |
| Ackerman, BH; Cawley, MJ; Digwood-Lettieri, S; Guilday, RJ; Haith, LR; Patton, ML; Reilly, KJ | 1 |
2 review(s) available for levofloxacin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
[Therapeutic experience with levofloxacin in pneumonia and COPD].
Topics: Algorithms; Anti-Bacterial Agents; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Levofloxacin; Multicenter Studies as Topic; Ofloxacin; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Recurrence; Treatment Outcome | 2009 |
Achilles tendon rupture associated with combination therapy of levofloxacin and steroid in four patients and a review of the literature.
Topics: Achilles Tendon; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Casts, Surgical; Female; Follow-Up Studies; Glucocorticoids; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Physical Therapy Modalities; Prednisolone; Pulmonary Disease, Chronic Obstructive; Rupture, Spontaneous; Walkers | 2007 |
13 trial(s) available for levofloxacin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.
Topics: Acute Disease; Aged; Biomarkers; C-Reactive Protein; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive | 2021 |
Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Topics: Aged; Anti-Bacterial Agents; Bronchitis, Chronic; Dioxolanes; Double-Blind Method; Female; Fluoroquinolones; Follow-Up Studies; Forced Expiratory Volume; Humans; Levofloxacin; Male; Middle Aged; Piperazines; Pulmonary Disease, Chronic Obstructive; Secondary Prevention; Severity of Illness Index; Time Factors; Treatment Outcome | 2013 |
The effect of indacaterol during an acute exacerbation of COPD.
Topics: Acute Disease; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Aged; Albuterol; Bronchodilator Agents; Drug Therapy, Combination; Hospitalization; Humans; Indans; Ipratropium; Levofloxacin; Male; Methylprednisolone; Nebulizers and Vaporizers; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Quinolones; Treatment Outcome | 2013 |
[Infectious exacerbation of chronic obstructive pulmonary disease: prospects for high-dose levofloxacin therapy].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2013 |
Efficacy of levofloxacin versus cefuroxime in treating acute exacerbations of chronic obstructive pulmonary disease.
Topics: Aged; Anti-Bacterial Agents; Bacteria; Cefuroxime; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Patient Acuity; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2013 |
Performance of the EXAcerbations of chronic pulmonary disease tool patient-reported outcome measure in three clinical trials of chronic obstructive pulmonary disease.
Topics: Aged; Anti-Bacterial Agents; Bronchodilator Agents; Cohort Studies; Female; Humans; Levofloxacin; Male; Medical Records; Middle Aged; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Pyridones; Reproducibility of Results; Severity of Illness Index; Sulfones; Surveys and Questionnaires; Time Factors | 2014 |
Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacterial Load; Double-Blind Method; England; Female; Humans; Levofloxacin; Lung; Male; Middle Aged; Neutrophils; Pulmonary Disease, Chronic Obstructive; Sputum; Time Factors; Treatment Outcome | 2014 |
Prulifloxacin vs Levofloxacin for Exacerbation of COPD after Failure of Other Antibiotics.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Dioxolanes; Disease Progression; Female; Fluoroquinolones; Follow-Up Studies; Humans; Levofloxacin; Male; Piperazines; Pulmonary Disease, Chronic Obstructive; Recurrence; Retreatment; Single-Blind Method; Symptom Assessment; Symptom Flare Up; Treatment Failure | 2016 |
Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Bronchitis, Chronic; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; Leukocyte Count; Levofloxacin; Macrophages, Alveolar; Male; Middle Aged; Ofloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; Urea; Young Adult | 2012 |
TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Double-Blind Method; Etanercept; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Immunoglobulin G; Levofloxacin; Male; Middle Aged; Ofloxacin; Prednisone; Pulmonary Disease, Chronic Obstructive; Receptors, Tumor Necrosis Factor; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Progression; Double-Blind Method; Female; Germany; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Statistics, Nonparametric; Treatment Outcome | 2004 |
Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
Topics: Amoxicillin; Anti-Infective Agents; Cefuroxime; Clarithromycin; Female; Follow-Up Studies; Forced Expiratory Volume; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Oximetry; Pulmonary Disease, Chronic Obstructive; Quality of Life; Recurrence; Survival Rate; Time Factors; Treatment Outcome | 2007 |
Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval.
Topics: Aged; Bronchitis, Chronic; Cefuroxime; Female; Heart Failure; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Risk Factors; Treatment Outcome | 2007 |
19 other study(ies) available for levofloxacin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Chryseobacterium indolegenes infection in a patient with chronic obstructive pulmonary disease.
Topics: Aged; Anti-Bacterial Agents; C-Reactive Protein; Chryseobacterium; Culture Techniques; Flavobacteriaceae Infections; Humans; Levofloxacin; Male; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Sputum | 2017 |
Sphingobacterium spiritivorum bacteremia due to cellulitis in an elderly man with chronic obstructive pulmonary disease and congestive heart failure: a case report.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cellulitis; Gram-Negative Bacterial Infections; Heart Failure; Humans; Levofloxacin; Male; Meropenem; Pulmonary Disease, Chronic Obstructive; Shock, Septic; Sphingobacterium; Thienamycins; Treatment Outcome | 2017 |
Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Brain Infarction; Chorea; Dyskinesia, Drug-Induced; Humans; Levofloxacin; Magnetic Resonance Imaging; Male; Pulmonary Disease, Chronic Obstructive; Thalamus | 2018 |
Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis.
Topics: Azithromycin; Humans; Levofloxacin; NF-kappa B; Pulmonary Disease, Chronic Obstructive; Quality of Life; Sarcoidosis, Pulmonary | 2013 |
Frequency of Streptococcus pneumonia and Haemophilus influenza in acute exacerbation of chronic obstructive airway disease and their sensitivity to levofloxacin.
Topics: Aged; Anti-Bacterial Agents; Cross-Sectional Studies; Disease Progression; Female; Haemophilus influenzae; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Pulmonary Disease, Chronic Obstructive; Sputum; Streptococcus pneumoniae | 2014 |
Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genetic Variation; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Nalidixic Acid; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Sequence Analysis, DNA | 2015 |
Unsuspected tuberculosis in COPD and use of levofloxacin: diagnostic challenges.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Antitubercular Agents; Body Mass Index; Delayed Diagnosis; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypertension; Levofloxacin; Mycobacterium tuberculosis; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Treatment Outcome; Tuberculosis, Pulmonary | 2014 |
Effect of Fluoroquinolones and Macrolides on Eradication and Resistance of Haemophilus influenzae in Chronic Obstructive Pulmonary Disease.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Haemophilus influenzae; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Pulmonary Disease, Chronic Obstructive | 2016 |
[Levofloxacin. expediency of high-dose regimens in therapy of lower respiratory tract infections].
Topics: Community-Acquired Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Pneumonia; Pulmonary Disease, Chronic Obstructive | 2011 |
[The use of levofloxacin for the empirical treatment of exacerbations of mild, chronic COPD: Is it justified in under-65-years-old patients with no comorbidity?].
Topics: Anti-Infective Agents; Humans; Levofloxacin; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections | 2002 |
Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting.
Topics: Adolescent; Adult; Aged; Alberta; Ambulatory Care; Analysis of Variance; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Emergency Service, Hospital; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2003 |
Levofloxacin-associated Achilles tendon rupture and tendinopathy.
Topics: Achilles Tendon; Aged; Aged, 80 and over; Anti-Infective Agents; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Rupture; Tendon Injuries | 2003 |
In vivo development of high-level fluoroquinolone resistance in Streptococcus pneumoniae in chronic obstructive pulmonary disease.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Pulmonary Disease, Chronic Obstructive; Serotyping; Streptococcus pneumoniae | 2005 |
[Levofloxacin-induced tendon rupture with fatal outcome].
Topics: Achilles Tendon; Aged; Anti-Bacterial Agents; Comorbidity; Fatal Outcome; Humans; Levofloxacin; Male; Ofloxacin; Pneumothorax; Pulmonary Disease, Chronic Obstructive; Rib Fractures; Rupture, Spontaneous; Subcutaneous Emphysema; Tendinopathy | 2006 |
Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
Topics: Adult; Aged; Area Under Curve; Blood Chemical Analysis; Bronchitis, Chronic; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chlamydophila pneumoniae; Chromatography, High Pressure Liquid; Female; Haemophilus influenzae; Humans; Levofloxacin; Male; Mass Spectrometry; Microbial Sensitivity Tests; Middle Aged; Mycoplasma pneumoniae; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Streptococcus pneumoniae; Time Factors | 2007 |
[Fluoroquinolone-induced Achilles tendon rupture].
Topics: Achilles Tendon; Aged; Anti-Bacterial Agents; Bronchitis; Diabetes Mellitus, Type 1; Female; Humans; Levofloxacin; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Risk Factors; Rupture; Tendinopathy; Tendon Injuries; Ultrasonography | 2008 |
[Achilles pain and functional impotence in a patient with chronic obstructive pulmonary disease with pneumonia. Tendon rupture caused by levofloxacin].
Topics: Achilles Tendon; Aged; Anti-Infective Agents; Humans; Levofloxacin; Male; Ofloxacin; Pain; Pneumonia; Pulmonary Disease, Chronic Obstructive; Rupture | 2001 |
Possible levofloxacin-induced acute hepatocellular injury in a patient with chronic obstructive lung disease.
Topics: Acute Disease; Aged; Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Infusions, Intravenous; Levofloxacin; Liver; Liver Diseases; Liver Function Tests; Ofloxacin; Pulmonary Disease, Chronic Obstructive | 2001 |
Levofloxacin-induced toxic epidermal necrolysis in an elderly patient.
Topics: Aged; Anti-Infective Agents; Community-Acquired Infections; Female; Fluid Therapy; Humans; Levofloxacin; Ofloxacin; Pneumonia; Pulmonary Disease, Chronic Obstructive; Skin; Stevens-Johnson Syndrome | 2002 |